Current Indications for Stenting: Symptoms or SurvivalCME
References
- Baigent C , Blackwell L , Collins R , .; Antithrombotic Trialists' (ATT) Collaboration Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30; 373 9678: 1849– 60.
- Yeh RW , Secemsky EA , Kereiakes DJ , .; DAPT Study Investigators Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016 Apr 26; 315 16: 1735– 49.
- Baigent C , Keech A , Kearney PM , .; Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 Oct 8; 366 9493: 1267– 78.
- Amin AP , Bachuwar A , Reid KJ , Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status. J Am Coll Cardiol. 2013 May 28; 61 21: 2130– 8.
- Wilson SR , Scirica BM , Braunwald E , Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. J Am Coll Cardiol. 2009 Apr 28; 53 17: 1510– 6.
- Poole-Wilson PA , Lubsen J , Kirwan BA , .; Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet. 2004 Sep 4–10; 364 9437: 849– 57.
- Bangalore S , Steg G , Deedwania P , .; REACH Registry Investigators β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 3; 308 13: 1340– 9.
- Dondo TB , Hall M , West RM , β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction. J Am Coll Cardiol. 2017 Jun 6; 69 22: 2710– 2720.
- Keeley EC , Boura JA , Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003 Jan 4; 361 9351: 13– 20.
- Arnold SV , Kosiborod M , Li Y , Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial. Circ Cardiovasc Qual Outcomes. 2014 Nov; 7 6: 844– 50.
- Rinfret S , Grines CL , Cosgrove RS , .; Stent-PAMI Investigators Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial. J Am Coll Cardiol. 2001 Nov 15; 38 6: 1614– 21.
- Nordmann AJ , Hengstler P , Harr T , Young J , Bucher HC. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Am J Med. 2004 Feb 15; 116 4: 253– 62.
- O'Donoghue M , Boden WE , Braunwald E , Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008 Jul 2; 300 1: 71– 80.
- Fox KA , Clayton TC , Damman P , .; FIR Collaboration Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010 Jun 1; 55 22: 2435– 45.
- Kim J , Henderson RA , Pocock SJ , Clayton T , Sculpher MJ , Fox KA ; RITA-3 Trial Investigators. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J Am Coll Cardiol. 2005 Jan 18; 45 2: 221– 8.
- Lin GA , Dudley RA , Redberg RF. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007 Aug 13–27; 167 15: 1604– 9.
- Rothberg MB , Sivalingam SK , Ashraf J , Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med. 2010 Sep 7; 153 5: 307– 13.
- Yusuf S , Zucker D , Peduzzi P , Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994 Aug 27; 344 8922: 563– 70.
- Chan PS , Patel MR , Klein LW , Appropriateness of percutaneous coronary intervention. JAMA. 2011 Jul 6; 306 1: 53– 61.
- Boden WE , O'Rourke RA , Teo KK , .; COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007 Apr 12; 356 15: 1503– 16.
- Kereiakes DJ , Teirstein PS , Sarembock IJ , The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 2007 Oct 16; 50 16: 1598– 603.
- Hilliard AA , From AM , Lennon RJ , Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents. JACC Cardiovasc Interv. 2010 Feb; 3 2: 172– 9.
- Frye RL , August P , Brooks MM , .; BARI 2D Study Group A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009 Jun 11; 360 24: 2503– 15.
- Spertus JA , Maron DJ , Cohen DJ , .; Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Investigators and Coordinators Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6 4: 409– 18.
- Emond M , Mock MB , Davis KB , Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994 Dec; 90 6: 2645– 57.
- Mancini GB , Hartigan PM , Bates ER , Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. Am Heart J. 2013 Sep; 166 3: 481– 7.
- Fihn SD , Gardin JM , Abrams J , .; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; American College of Physicians; American Association for Thoracic Surgery; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012 Dec 18; 60 24: e44– e164.
- Hachamovitch R , Hayes SW , Friedman JD , Cohen I , Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003 Jun 17; 107 23: 2900– 7.
- Shaw LJ , Weintraub WS , Maron DJ , Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012 Aug; 164 2: 243– 50.
- Go AS , Mozaffarian D , Roger VL , .; American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1; 127 1: e6– e245.
- Brown N , Melville M , Gray D , Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart. 1999 Apr; 81 4: 352– 8.
- Brorsson B , Bernstein SJ , Brook RH , Werkö L. Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart. 2002 Feb; 87 2: 140– 5.
- Arnold SV , Morrow DA , Lei Y , Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial. Circ Cardiovasc Qual Outcomes. 2009 Jul; 2 4: 344– 53.
- Weintraub WS , Spertus JA , Kolm P , .; COURAGE Trial Research Group Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008 Aug 14; 359 7: 677– 87.
- Rogers WJ , Coggin CJ , Gersh BJ , Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS). Circulation. 1990 Nov; 82 5: 1647– 58.
- Abdallah MS , Wang K , Magnuson EA , .; SYNTAX Trial Investigators Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease. J Am Coll Cardiol. 2017 Apr 25; 69 16: 2039– 50.
- Stone PH , Gratsiansky NA , Blokhin A , Huang IZ , Meng L ; ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol. 2006 Aug 1; 48 3: 566– 75.
- Kosiborod M , Arnold SV , Spertus JA , Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol. 2013 May 21; 61 20: 2038– 45.
- Ezekowitz MD , Hossack K , Mehta JL , Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J. 1995 Mar; 129 3: 527– 35.
- Lauer B , Junghans U , Stahl F , Kluge R , Oesterle SN , Schuler G. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol. 1999 Nov 15; 34 6: 1663– 70.
- Leon MB , Kornowski R , Downey WE , A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol. 2005 Nov 15; 46 10: 1812– 9.
- Al-Lamee R , Thompson D , Dehbi HM ; ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018 Jan 6; 391 10115: 31– 40.
DOI: https://doi.org/10.14797/mdcj-14-1-7 | Journal eISSN: 1947-6108
Language: English
Page range: 7 - 13
Published on: Jan 1, 2018
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2018 Suzanne V. Arnold, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.